Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors

Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors

Lung cancer is a malignant tumor with high incidence rate and mortality worldwide. Non-small cell lung cancer (NSCLC) is the most common malignancy. The traditional treatment of NSCLC mainly depends on chemical drugs. In recent years, immunotherapy has become a hot spot in the treatment of NSCLC and...

Full description

Bibliographic Details
Main Authors: WANG Shuo, DENG Yuntian, PENG Huan, ZHANG Xiangfeng
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2023-03-01
Series:Xiehe Yixue Zazhi
Subjects:
non-small cell lung cancer
immunotherapy
ctla-4
pd-1
pd-l1
Online Access:https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0151

Internet

https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0151

Similar Items